China will be the fifth largest pharmaceutical market by 2010 and the top destination for the investment of foreign pharmaceutical companies. Leading pharmaceutical companies invest more in China in 2007. Eli Lilly established its Lilly Asian Ventures in 2007 with a geographic focus on east and south Asia, particularly India and China; Roche announced the plan to establish drug development center in China; Johnson & Johnson (China) , a wholly owned subsidiary of Johnson & Johnson, plans to buy more shares in Xi'an-Janssen Pharmaceutical from the latter's Chinese shareholders. These pharmaceutical giants are catching China opportunities in VC, R&D, manufacture, and sales, and local Asian players determines not to lag behind. Dawnrays is a good example in case.

Dawnrays Pharmaceutical (Holdings) Ltd. (HXEx:2348 ) has 6 subsidiaries: Suzhou Dawnrays Pharmaceutical, Suzhou Dawnrays Chemical, Shanghai Dawnrays Chemical , Dawnrays Pharma Tech(Nantong), Dawnrays Pharma (Hong Kong), and Guangdong Dawnrays Pharmaceutical.

Dawnrays focuses on the R&D, manufacture, and sales of cephalosporin and specialty drugs. Its antibiotics include intermediates, APIs, formulations cover anti-allergic, cardiovascular, digestive, urinary, and endocrine drugs in tablets, capsules, and granulate forms.

In the section of cephalosporin, the company has integrated the production chain of intermediates, APIs, and formulations. It is the first Chinese company that manufactures cephalosporin via solvent crystallization. Supported by its advanced technology platform for the synthesis of cephalosporin, the company has formed cephalosporin line of rich product varieties, complete accessory functions, and adequate capacity potential. The quality of the products reaches leading international standard. Dawnrays has established its presence in the fields of cardiovascular and endocrine drugs. Its Amlozen® (Amlodipine Besylate Tablets) and Cecoride ® (Cetirizine Hydrochloride Tablets) have good market shares.

Dawnrays contributed RMB 1.2 million worth of much-needed drugs to help those suffer from the May 12 earthquake that hit Wenchuan of Sichuan province, China. The drugs include Cepcal® (ceftriaxone sodium for injection), Cepchine® (cefotaxime sodium for injection), Azithromycin tablets, and Roxithromycin tablets.

Dawnrays has been devoting itself to the health of human beings. With the high sense of social responsibility, long business vision, and the continuous effort in technological innovations. Dawnrays continues to contribute to the society by producing low-cost high quality medicines in the market and aspire to become one of the best pharmaceutical companies worldwide.